Mon panier

ALPL

ALPL Informations sur la molécule

Nom anglaisAlkaline phosphatase, tissue-nonspecific isozymeNombre de médicaments commercialisés1
Nombre de médicaments cliniques3Alias de la cibleAlkaline Phosphatase, Biomineralization Associated,EC:3.1.3.1,Alkaline Phosphatase Liver/Bone/Kidney Isozyme,Liver/Bone/Kidney-Type Alkaline Phosphatase,ALPL,AP-TNAP,Alkaline Phosphatase, Liver/Bone/Kidney,Tissue Non-Specific Alkaline Phosphatase,TNSALP,Alkaline Phosphatase, Tissue-Nonspecific Isozyme,Tissue-Nonspecific ALP,EC 3.1.3.1,APTNAP,TNALP,TNAP,HOPS
Phase de R&D la plus avancéeApproved
Nom anglaisAlkaline phosphatase, tissue-nonspecific isozyme
Alias de la cibleAlkaline Phosphatase, Biomineralization Associated,EC:3.1.3.1,Alkaline Phosphatase Liver/Bone/Kidney Isozyme,Liver/Bone/Kidney-Type Alkaline Phosphatase,ALPL,AP-TNAP,Alkaline Phosphatase, Liver/Bone/Kidney,Tissue Non-Specific Alkaline Phosphatase,TNSALP,Alkaline Phosphatase, Tissue-Nonspecific Isozyme,Tissue-Nonspecific ALP,EC 3.1.3.1,APTNAP,TNALP,TNAP,HOPS
Nombre de médicaments commercialisés1
Nombre de médicaments cliniques3
Phase de R&D la plus avancéeApproved

ALPL Liste de produits

  • Attribut

    Protein (4)

  • Bibliothèque de produits

    En ligne (4)

  • Espèces

    Human (2)Mouse (1)Cynomolgus (1)

  • Étiquette

    His Tag (4)

  • Marqueur

    Unconjugated (3)HRP Labeled (1)

ALPLContexte de la molécule

This gene encodes a member of the alkaline phosphatase family of proteins. There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2, while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature enzyme. This enzyme may play a role in bone mineralization. Mutations in this gene have been linked to hypophosphatasia, a disorder that is characterized by hypercalcemia and skeletal defects.

ALPLAlias de la molécule

AP-TNAP, APTNAP, HOPS, HPPA, HPPC, HPPI, HPPO, TNALP, TNAP, TNS-ALP, TNSALP

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
ALXN-1850ALXN-1850Phase 3 ClinicalAlexion Pharmaceuticals IncHypophosphatasia
Details
DS-1211DS-1211Phase 2 ClinicalDaiichi Sankyo Co Ltd, Sanford Burnham Prebys Medical Discovery InstituteOssification, Heterotopic; Pseudoxanthoma Elasticum
Details
ALXN-1910ALXN-1910Phase 1 ClinicalAlexion Pharmaceuticals Inc
Details

Informations sur les médicaments commercialisés

Nom anglaisCode de recherchePhase de R&DEntreprisePlus ancien nom de marquePays d'approbation le plus ancienIndication la plus ancienneSociété d'approbation la plus ancienneDate d'approbation la plus ancienneIndicationEssai clinique
Asfotase alfasTNALP-FcD10; ALXN-1215; sALP-FcD10; ENB-0040ApprovedAlexion Pharmaceuticals IncStrensiqJapanHypophosphatasiaAlexion Pharmaceuticals Inc2015-07-03Hypophosphatasia
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments commercialisés
  • Informations sur les médicaments cliniques